Oligonucleotide Synthesis Market to Observe Highest Growth of USD 10.17 billion with an Excellent CAGR of 12.55% by 2032 | Key Players- Agilent Technologies, ATDBio Ltd., Bio-Synthesis Inc.

The recently published Oligonucleotide Synthesis Market study report by Polaris Market Research reveals that the global market was USD 3.55 billion in 2023, with a CAGR of 12.55% projected from 2024 to 2032. The global market is expected to offer an absolute opportunity of USD 10.17 billion by 2032.

Governments covering varied regions are massively funding research and development in zones involving pharmaceutical and biotechnology together with an escalating pool of venture capital savings, which emerges as the significant propeller of the market growth. Also, the growth is extensively supported by the growing usage of synthesized oligonucleotides in molecular diagnostics, and clinical solicitation plays an important part. The rise in the market purview is credited to their manifold applications spanning from genetic testing to earmarked therapeutics.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐀 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐓𝐨 𝐆𝐚𝐢𝐧 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market/request-for-sample

Oligonucleotides can be configured either enzymatically via cleavage or extensive biomolecules or via earmarked chemical synthesis. It is a chemical procedure by which nucleoside phosphoramidites, a critical monomeric segment of oligonucleotides, are synthesized. Nucleoside phosphoramidites themselves are byproducts of organic or man-made nucleosides. They are compound molecules comprising a covalently connected nucleoside and a phosphate category. Nucleotides are connected in a particular order to configure the wanted commodity.

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐏𝐫𝐨𝐟𝐢𝐥𝐞

The market is splintered and is expected to observe contention because of several player's existence. Major companies in the oligonucleotide synthesis market are noted below:
• Agilent Technologies
• ATDBio Ltd.
• Bio-Synthesis Inc.
• Biosearch Technologies
• Eurofins Genomics
• GE Healthcare
• Genewiz
• GenScript Corporation
• Integrated DNA Technologies (IDT)
• LGC Biosearch Technologies
• Merck KGaA (including Sigma-Aldrich)
• Nitto Denko Avecia Inc.
• Thermo Fisher Scientific
• TriLink BioTechnologies
• Twist Bioscience

𝐍𝐞𝐞𝐝 𝐌𝐨𝐫𝐞 𝐅𝐨𝐫 𝐘𝐨𝐮𝐫 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐢𝐫𝐞𝐜𝐭𝐥𝐲 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/buy/3883/2

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬

1. Rising Demand in Research: Increasing research activities in the field of genomics and molecular biology are driving the demand for oligonucleotides. This includes applications in PCR, sequencing, and gene synthesis.
2. Advancements in Therapeutics: Oligonucleotide-based therapies, such as antisense oligonucleotides and siRNA, are gaining traction for the treatment of genetic disorders, cancers, and other diseases.
3. Technological Advancements: Improvements in synthesis technologies, such as high-throughput synthesis and automation, have enhanced the efficiency and lowered the cost of oligonucleotide production.
4. Expanding Applications in Diagnostics: The growing need for accurate and rapid diagnostic tests, especially in infectious disease detection and personalized medicine, is boosting the market.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭

• The primary factors propelling the growth of oligonucleotide synthesis are the expanding usage of synthesized oligos in applications involving clinical and molecular diagnostics, together with the progressive suffusion of government funding.
• The oligonucleotide synthesis market analysis is mainly based on product, application, and region.
• In 2023, North America dominated the market.
• The market in Asia Pacific will increase as a result of prominent players demonstrating escalated engrossment in optimizing gains within surfacing markets.

𝐑𝐞𝐚𝐝 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐈𝐧𝐝𝐞𝐱 𝐨𝐟 𝐟𝐮𝐥𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐭𝐮𝐝𝐲 𝐚𝐭:https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

By Product
• Synthesized Oligonucleotide Products
• Equipment
• Reagents
• Services

By Application
• PCR Assays and Panels
• PCR Primers
• DNA Microarrays
• Sequencing
• Antisense Oligonucleotides
• Fluorescence In Situ Hybridization (FISH)
• Others

𝐎𝐥𝐢𝐠𝐨𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐒𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• In 2023, the synthesized oligonucleotide products segment is expected to witness highest growth during forecast period owing to increased prevalence of genomic studies
• PCR primers segment is expected to dominate the oligonucleotide synthesis market during forecast period. This is attributed to increase in detecting and measuring gene expression
• In 2023, North America accounted for the largest revenue share due to presence of major players, technological advancements, and growing awareness of genetic disorders.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞-𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏𝐌𝐑'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Virus Filtration Market: https://www.polarismarketresearch.com/industry-analysis/virus-filtration-market

Durable Medical Equipment Market: https://www.polarismarketresearch.com/industry-analysis/durable-medical-equipment-market

Point Of Care (Poc) Diagnostics Market: https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market

Surgical Microscope Market: https://www.polarismarketresearch.com/industry-analysis/surgical-microscope-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.